E3 ubiquitin ligase, WWP1, interacts with AMPKα2 and down-regulates its expression in skeletal muscle C2C12 cells

Journal of Biological Chemistry

Volumn 288, Issue 7, 2013, Pages 4673-4680

  Lee, Jung Ok ^a   Lee, Soo Kyung ^a   Kim, Nami ^a   Kim, Ji Hae ^a   You, Ga Young ^a   Moon, Ji Wook ^a   Jie, Sha ^a   Kim, Su Jin ^a   Lee, Yong Woo ^a   Kang, Ho Jin ^a   Lim, Yongchul ^a   Park, Sun Hwa ^a   Kim, Hyeon Soo ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

C2C12 CELLS; CULTURE CONDITIONS; DIRECT INTERACTIONS; DOWN-REGULATION; HIGH GLUCOSE; PROTEASOMES; SKELETAL MUSCLE; UBIQUITIN; UBIQUITIN LIGASES;

MUSCLE;

GLUCOSE;

E3 UBIQUITIN PROTEIN LIGASE WWP1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE ALPHA2; MESSENGER RNA; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME DEGRADATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MALE; MOUSE; MUSCLE CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SKELETAL MUSCLE; UBIQUITINATION;

ANIMALS; CYCLIC AMP-DEPENDENT PROTEIN KINASE RIIALPHA SUBUNIT; DOWN-REGULATION; GENE SILENCING; GLUCOSE; GLUTATHIONE TRANSFERASE; HEK293 CELLS; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MODELS, ANIMAL; MUSCLE, SKELETAL; PLASMIDS; RNA, MESSENGER; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES;

EID: 84874077399     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.406009     Document Type: Article

References (31)

1. Holmes, B. F., Kurth-Kraczek, E. J., and Winder, W. W. (1999) Chronic activation of 5 '-AMP-activated protein kinase increases GLUT-4, hexokinase, and glycogen in muscle. J. Appl. Physiol. 87, 1990-1995
2. Song, H., Guan, Y., Zhang, L., Li, K., and Dong, C. (2010) SPARC interacts with AMPK and regulates GLUT4 expression. Biochem. Biophys. Res. Commun. 396, 961-966
3. Nishino, Y., Miura, T., Miki, T., Sakamoto, J., Nakamura, Y., Ikeda, Y., Kobayashi, H., and Shimamoto, K. (2004) Ischemic preconditioning activates AMPK in a PKC-dependent manner and induces GLUT4 up-regulation in the late phase of cardioprotection. Cardiovasc. Res. 61, 610-619
4. Kramer, H. F., and Witczak., C. A., Fujii, N., Jessen, N., Taylor, E. B., and Arnolds., D. E., Sakamoto, K., Hirshman, M. F., and Goodyear, L. J. (2006) Distinct signals regulate AS160 phosphorylation in response to insulin, AICAR, and contraction in mouse skeletal muscle. Diabetes 55, 2067-2076
5. Buhl, E. S., Jessen, N., Schmitz, O., Pedersen, S. B., Pedersen, O., and Holman., G. D., and Lund, S. (2001) Chronic treatment with 5-aminoimidazole-4- carboxamide-1-beta-D-ribofuranoside increases insulin-stimulated glucose uptake and GLUT4 translocation in rat skeletal muscles in a fiber type-specific manner. Diabetes 50, 12-17
6. Koistinen, H. A., Galuska, D., Chibalin, A. V., Yang, J., and Zierath., J. R., Holman, G. D., and Wallberg-Henriksson, H. (2003) 5-amino-imidazole carboxamide riboside increases glucose transport and cell-surface GLUT4 content in skeletal muscle from subjects with type 2 diabetes. Diabetes 52, 1066-1072
7. Karlsson, H. K., and Chibalin., A. V., Koistinen, H. A., Yang, J., Koumanov, F., Wallberg-Henriksson, H, Zierath, J. R., and Holman, G. D. (2009) Kinetics of GLUT4 trafficking in rat and human skeletal muscle. Diabetes 58, 847-854
8. Yang, J., and Holman, G. D. (2005) Insulin and contraction stimulate exocytosis, but increased AMP-activated protein kinase activity resulting from oxidative metabolism stress slows endocytosis of GLUT4 in cardiomyocytes. J. Biol. Chem. 280, 4070-4078
9. Shi, L., Qin, N., Hu, L., Liu, L., Duan, H, and Niu, W. (2011) Tiliroside-derivatives enhance GLUT4 translocation via AMPK in muscle cells. Diabetes Res. Clin. Pract. 92, e41-46
10. Yamaguchi, S., Katahira, H., Ozawa, S., Nakamichi, Y., Tanaka, T., Shimoyama, T., Takahashi, K., Yoshimoto, K., Imaizumi, M. O., Nagamatsu, S., and Ishida, H. (2005) Activators of AMP-activated protein kinase enhance GLUT4 translocation and its glucose transport activity in 3T3-L1 adipocytes. Am. J. Physiol. Endocrinol. Metab. 289, E643-E649
11. Luo, Z., and Saha., A. K., Xiang, X., and Ruderman, N. B. (2005) AMPK, the metabolic syndrome and cancer. Trends Pharmacol. Sci. 26, 69-76
12. Zhang, B. B., Zhou, G., and Li, C. (2009) AMPK: an emerging drug target for diabetes and the metabolic syndrome. Cell Metab. 9, 407-416
13. Hardie, D. G., and Carling, D. (1997) The AMP-activated protein kinase-fuel gauge of the mammalian cell? Eur. J. Biochem. 246, 259-273
14. Makinde, A. O., Gamble, J., and Lopaschuk, G. D. (1997) Upregulation of 5'-AMP-activated protein kinase is responsible for the increase in myocardial fatty acid oxidation rates following birth in the newborn rabbit. CircRes. 80, 482-489
15. Ai, H., Ihlemann, J., Hellsten, Y., Lauritzen, H. P., and Hardie., D. G., Galbo, H., and Ploug, T. (2002) Effect of fiber type and nutritional state on AICAR-and contraction-stimulated glucose transport in rat muscle. Am. J. Physiol. Endocrinol. Metab. 282, E1291-1300
16. Zong, H., and Ren., J. M., Young, L. H., Pypaert, M., Mu, J., and Birnbaum., M. J., and Shulman, G. I. (2002) AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proc. Natl. Acad. Sci. U.S.A. 99, 15983-15987
17. Henin, N., and Vincent., M. F., Gruber, H. E., and Van den Berghe, G. (1995) Inhibition of fatty acid and cholesterol synthesis by stimulation of AMP-activated protein kinase. FASEBJ. 9, 541-546
18. Al-Hakim, A. K., Zagorska, A., Chapman, L., Deak, M., Peggie, M., and Alessi, D. R. (2008) Control of AMPK-related kinases by USP9X and atypical Lys(29)/Lys(33)-linked polyubiquitin chains. Biochem. J. 411, 249-260
19. Joly, E., Roduit, R., Peyot, M. L., and Habinowski., S. A., Ruderman, N. B., Witters, L. A., and Prentki, M. (2009) Glucose represses PPARα gene expression via AMP-activated protein kinase but not via p38 mitogen-activated protein kinase in the pancreatic beta-cell. J. Diabetes 1, 263-272
20. Saha, A. K., and Xu., X. J., Lawson, E., Deoliveira, R., Brandon, A. E., and Kraegen., E. W., and Ruderman, N. B. (2010) Downregulation of AMPK accompanies leucine-and glucose-induced increases in protein synthesis and insulin resistance in rat skeletal muscle. Diabetes 59, 2426-2434
21. Hershko, A. (2005) The ubiquitin system for protein degradation and some of its roles in the control of the cell division cycle. Cell Death Differ. 12, 1191-1197
22. Qi, J., Gong, J., Zhao, T., Zhao, J., Lam, P., Ye, J., Li, J. Z., Wu, J., and Zhou., H. M., and Li, P. (2008) Downregulation of AMP-activated protein kinase by Cidea-mediated ubiquitination and degradation in brown adipose tissue. EMBOJ. 27, 1537-1548
23. Lee, W. J., Song, K. H, Koh, E. H., Won, J. C, Kim, H. S., Park, H. S., Kim, M. S., Kim, S. W., Lee, K. U., and Park, J. Y. (2005) α-Lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle. Biochem. Biophys. Res. Commun. 332, 885-891
24. Martin, T. L., Alquier, T., Asakura, K., Furukawa, N., Preitner, F., and Kahn, B. B. (2006) Diet-induced obesity alters AMP kinase activity in hypothalamus and skeletal muscle. J. Biol. Chem. 281, 18933-18941
25. Assifi, M. M., Suchankova, G., Constant, S., Prentki, M., and Saha., A. K., and Ruderman, N. B. (2005) AMP-activated protein kinase and coordination of hepatic fatty acid metabolism of starved/carbohydrate-refed rats. Am. J. Physiol. Endocrinol. Metab. 289, E794-800
26. Fryer, L. G., Parbu-Patel, A., and Carling, D. (2002) The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J. Biol. Chem. 277, 25226-25232
27. Saha, A. K., and Avilucea., P. R., Ye, J. M., Assifi, M. M., and Kraegen., E. W., and Ruderman, N. B. (2004) Pioglitazone treatment activates AMP-activated protein kinase in rat liver and adipose tissue in vivo. Biochem. Biophys. Res. Commun. 314, 580-585
28. Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., Musi, N., Hirshman, M. F., Goodyear, L. J., and Moller, D. E. (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108, 1167-1174
29. Thomson, D. M., and Hansen., M. D., and Winder, W. W. (2008) Regulation of the AMPK-related protein kinases by ubiquitination. Biochem. J. 411, e9-10
30. Zungu, M., and Schisler., J. C., Essop, M. F., McCudden, C., Patterson, C., and Willis, M. S. (2011) Regulation of AMPK by the ubiquitin proteasome system. Am. J. Pathol. 178, 4-11
31. Moreno, D., Viana, R., and Sanz, P. (2009) Two-hybrid analysis identifies PSMD11, a non-ATPase subunit of the proteasome, as a novel interaction partner of AMP-activated protein kinase. Int. J. Biochem. Cell Biol. 41, 2431-2439